Two types of structurally similar nicotinic agonists have very different biological and physicochemical properties. Neonicotinoids, important insecticides including imidacloprid and thiacloprid, are nonprotonated and selective for insects and their nicotinic receptors, whereas nicotinoids such as nicotine and epibatidine are cationic and selective for mammalian systems. We discovered that a mollusk acetylcholine binding protein (AChBP), as a structural surrogate for the extracellular ligand-binding domain of the nicotinic receptor, is similarly sensitive to neonicotinoids and nicotinoids. It therefore seemed possible that the proposed very different interactions of the neonicotinoids and nicotinoids might be examined with a single AChBP by using optimized azidochloropyridinyl photoaffinity probes. Two azidoneonicotinoids with a nitro or cyano group were compared with the corresponding desnitro or descyano azidonicotinoids. acetylcholine binding protein ͉ imidacloprid ͉ neonicotinoid insecticides ͉ nicotinic receptor ͉ photoaffinity labeling S elective toxicity is critical for insecticide use, combining outstanding effectiveness for pests with safety for humans and wildlife. Neonicotinoids, exemplified by the major imidacloprid (IMI), thiacloprid (THIA), and acetamiprid (ACE) (Figs. 1 and 2), are the most important new class of insecticides of the past three decades and are increasingly replacing the organophosphates and methylcarbamates. The favorable selectivity of the neonicotinoids occurs largely at the target level, which is the agonist binding site of the nicotinic acetylcholine (ACh) receptor (nAChR). Nicotine, the namesake of the nAChR, has been used for pest control since the 17th century despite the risk for people and limited insecticidal efficacy. In contrast, the new and nicotine-like neonicotinoids have low activity on mammalian relative to insect nAChRs, providing a mechanistic basis for their safety (1, 2).Primary insights into the structure and function of agonistgated ion channel complexes came from electron microscopy analysis of the Torpedo nAChR (3) and x-ray crystallography of ACh binding proteins (AChBPs), soluble homologues of the nAChR extracellular drug-binding domain (4-7). Nicotine and its more potent analog epibatidine (EPI) (Fig. 2) (8) played a major role in structural characterization of the agonist-binding domain. Protonation of these agonists at physiological pH is important for binding site interactions at the superfamily of neurotransmitter-gated ion channels (5, 7, 9-11). Neonicotinoids, on the other hand, are uncharged with an electronegative nitro or cyano pharmacophore (12, 13). The first step in understanding neonicotinoid binding sites was identification of the molecular determinants for target site resistance and sitedirected mutagenesis (14-16), but such studies do not provide a complete description of the binding site.We report here that AChBP from the saltwater mollusk Aplysia californica surprisingly shows high sensitivity to the neonicotinoids. Photoaffinity labelin...